Fri, March 4, 2011
Thu, March 3, 2011
Wed, March 2, 2011
[ Wed, Mar 02nd 2011 ] - Market Wire
BURCON AMENDS LETTER OF INTENT
Tue, March 1, 2011
Mon, February 28, 2011
Sun, February 27, 2011
Fri, February 25, 2011
Thu, February 24, 2011
Wed, February 23, 2011
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
PROTOX APPOINTS NEW DIRECTORS
Mon, February 21, 2011
Sun, February 20, 2011
Fri, February 18, 2011
Thu, February 17, 2011
Wed, February 16, 2011

NPS Pharmaceuticals to Present at Upcoming Health Care Conferences


//health-fitness.news-articles.net/content/2011/ .. present-at-upcoming-health-care-conferences.html
Published in Health and Fitness on Thursday, February 24th 2011 at 13:16 GMT by Market Wire   Print publication without navigation


BEDMINSTER, N.J.--([ BUSINESS WIRE ])--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) will present at the Citi 2011 Global Health Care Conference in New York on Tuesday, March 1, 2011 at 10:30 a.m. ET and the Cowen and Company 31st Annual Health Care Conference in Boston on Monday, March 7, 2011 at 2:30 PM ET. Presentations will be available as live webcasts with replays available approximately three hours after the presentation has concluded. Interested parties may access the webcasts from the investorsa™ calendar of events page on the NPS website at [ http://www.npsp.com/events ].

About NPS Pharmaceuticals

NPS Pharmaceuticals is an outsourcing-based development company focused on bringing biopharmaceuticals to patients with rare disorders and few, if any, therapeutic options. The company is advancing two Phase 3 registration programs, GATTEX® (teduglutide) in short bowel syndrome (SBS) and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) in hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.


Publication Contributing Sources